Whitton J L, Tishon A, Lewicki H, Gebhard J, Cook T, Salvato M, Joly E, Oldstone M B
Department of Immunology, Scripps Clinic and Research Foundation, La Jolla, California 92037.
J Virol. 1989 Oct;63(10):4303-10. doi: 10.1128/JVI.63.10.4303-4310.1989.
The cytotoxic T-lymphocyte (CTL) response to lymphocytic choriomeningitis virus infection determines the outcome of infection. Here we show that this response in BALB/c mice (H-2d), when analyzed both at the primary CTL level and using CTL clones, is predominantly monospecific. The vast majority of CTL have a common specificity for a single epitope in the virus nucleoprotein, which can be minimally identified by amino acids GVYMG. This epitope is presented by the Ld class I glycoprotein. We used these data to design a subunit CTL vaccine, whose effectiveness is demonstrated in the accompanying report (L. S. Klavinskis, J. L. Whitton, and M. B. A. Oldstone, J. Virol. 63:4311-4316, 1989). Further analysis indicates that, while CTL clones share a common minimal epitope, they differ in their ability to recognize cells infected with a related but distinct strain of lymphocytic choriomeningitis virus. Studies on the molecular nature of CTL cross-reactivity indicate that CTL induced by similar sequences may cross-react in a unidirectional manner. These novel observations suggest that CTL vaccines, to achieve optimal effectiveness, should not simply include virus sequences which will yield a CTL response; the immunizing sequences should also be selected to ensure that the fine specificities of the induced CTL are such that they maximize the chance of recognizing serotypically diverse strains.
细胞毒性T淋巴细胞(CTL)对淋巴细胞性脉络丛脑膜炎病毒感染的反应决定了感染的结果。在此我们表明,对BALB/c小鼠(H-2d)的这种反应,无论是在初级CTL水平进行分析还是使用CTL克隆进行分析,主要都是单特异性的。绝大多数CTL对病毒核蛋白中的单个表位具有共同的特异性,该表位最少可由氨基酸GVYMG鉴定。此表位由I类Ld糖蛋白呈递。我们利用这些数据设计了一种亚单位CTL疫苗,其有效性在随附报告中得到了证实(L. S. 克拉文斯基斯、J. L. 惠顿和M. B. A. 奥尔德斯通,《病毒学杂志》63:4311 - 4316,1989年)。进一步分析表明,虽然CTL克隆共享一个共同的最小表位,但它们识别感染相关但不同株淋巴细胞性脉络丛脑膜炎病毒的细胞的能力有所不同。对CTL交叉反应性分子本质的研究表明,由相似序列诱导的CTL可能以单向方式发生交叉反应。这些新的观察结果表明,为了达到最佳效果,CTL疫苗不应仅仅包含能引发CTL反应的病毒序列;免疫序列的选择还应确保所诱导CTL的精细特异性能够最大程度地增加识别血清型多样毒株的机会。